Back to results
US 12,741,022 B2Granted
Vaccines, vaccine priming, and antigen dose sparing
AssigneeAdjuvance Technologies, Inc.
InventorsJ. Tyler Martin, Eric Jon Farris, Anna Therese Lampe
Life of this patent
Estimating the term…
Abstract
The present application relates to new vaccines, improved vaccine priming, and antigen dose sparing in connection with triterpene glycoside saponin-derived adjuvants, salt forms thereof, and pharmaceutical compositions, as well as related methods.
Claims7
A pharmaceutical composition for priming or antigen dose-sparing comprising
- an antigen associated with influenza;
- and
- a compound
- or a pharmaceutically acceptable salt thereof.
1 more element
Dependencies are inferred from the claim text.